ABEONA THERAPEUTICS INC.: Funicular Funds, LP amends Schedule 13G stake filing
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Funicular Funds, LP amended its Schedule 13G filing on AbEona Therapeutics Inc., updating its passive stake disclosure with the SEC under accession number 0002073679-26-000173. The filing, submitted to the regulator, revises the fund's previously reported ownership position in the clinical-stage biotech. The exact size and percentage of the amended stake were not detailed in the headline disclosure. Investors should watch for further 13G or 13D filings to gauge whether Funicular's position is building or being trimmed.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.
Named in this story
Abeona Therapeutics Inc., Funicular Funds, LP